ANTHERA PHARMACEUTICALS, INC. Anthera Pharmaceuticals, Inc. announced the appointment of Brent Furse to its Board of Directors. Mr. Furse has over 25 years of healthcare commercial leadership experience with extensive experience in the areas of sales and marketing, commercial product launch and partnerships. He is currently President and Chief Commercial Officer of Cardiorentis AG, a company that is developing novel medicines for Acute Heart Failure.
Previously he was Chief Customer Officer & Executive Vice President at The Medicines Company. Prior to the Medicines Company, he worked in the cardiovascular divisions of Schering-Plough and Bristol-Myers Squibb. Concurrent with the appointment of Mr. Brent Furse, Mr. Sanford Zweifach resigned from the Company's Board of Directors.
